investorscraft@gmail.com

Intrinsic Value of Adamis Pharmaceuticals Corporation (ADMP)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2022-12-31 and quarterly data as of 2023-06-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2023202420252026202720282029203020312032203320342035203620372038203920402041204220432044204520462047

INCOME STATEMENT

Revenue growth rate, %0.0NaN
Revenue, $5NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m30NaN
Operating income, $m-25NaN
EBITDA, $m-24NaN
Interest expense (income), $mNaN
Earnings before tax, $m-26NaN
Tax expense, $m-0NaN
Net income, $m-26NaN

BALANCE SHEET

Cash and short-term investments, $m1NaN
Total assets, $m11NaN
Adjusted assets (=assets-cash), $m10NaN
Average production assets, $m1NaN
Working capital, $m-2NaN
Total debt, $m0NaN
Total liabilities, $m12NaN
Total equity, $m-1NaN
Debt-to-equity ratio0.000NaN
Adjusted equity ratio-0.195NaN

CASH FLOW

Net income, $m-26NaN
Depreciation, amort., depletion, $m1NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-26NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-1NaN
Free cash flow, $m-25NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m-2
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount